CICoach ImpactOS

Evidence Lab

Vitamin D3

Vitamin D is essential for bone and muscle health, and supplementation is most clearly useful when intake or status is inadequate. Evidence does not support treating vitamin D3 as a reliable ergogenic aid in already sufficient athletes.

Evidence rating: Strong

Published 8/14/2026 | Last reviewed 8/14/2026

Overview

Vitamin D is a fat-soluble vitamin involved in calcium balance, bone mineralization, neuromuscular function and many other physiological processes. Vitamin D3 (cholecalciferol) is a common supplemental form. The practical case for supplementation is strongest when dietary intake, sun exposure or measured vitamin D status is inadequate. Athlete meta-analyses have not shown a consistent overall improvement in strength or power from vitamin D supplementation, especially when baseline status is already sufficient. Correcting deficiency is a health priority, but that is different from expecting supraphysiological performance enhancement. Because vitamin D is fat soluble, excessive chronic intake can cause toxicity. Testing and individualized medical guidance are appropriate when deficiency, malabsorption, bone disease, kidney disease or high-dose treatment is being considered.

Common use

Preventing or correcting inadequate vitamin D intake or status and supporting bone and muscle health; not a routine performance booster for already sufficient athletes.

Common forms

Vitamin D3 (cholecalciferol) tablets, capsules, softgels and drops; vitamin D2 is another supplemental form. Doses are commonly labeled in micrograms or IU.

Practical notes

Use dietary intake, sun-exposure context and, when clinically appropriate, measured 25-hydroxyvitamin D status to guide decisions. Do not assume more vitamin D means better performance. Last evidence review: 14 August 2026.

Claim-level evidence

Strong

Vitamin D supplementation is most clearly indicated when intake or status is inadequate.

Population: People with low intake, limited sun exposure, deficiency risk or measured low 25-hydroxyvitamin D.

Correcting deficiency supports health; do not frame deficiency treatment as a special ergogenic strategy.

Limitations: The appropriate treatment dose depends on baseline status and clinical context.

Emerging / Mixed

Vitamin D supplementation does not consistently improve strength or power in athletes as a whole.

Population: Athletes and active adults across mixed baseline vitamin D status.

Do not expect a reliable performance gain when status is already sufficient.

Limitations: Studies differ in baseline status, dose, duration, sport and outcome measures.

Strong

Vitamin D is essential for calcium homeostasis and bone health.

Population: General adult population.

Maintain adequate vitamin D as part of bone-health and injury-risk management.

Limitations: This is a nutrient requirement, not evidence that higher-than-needed doses improve performance.

Dosing context

  • General adult intake context - NIH ODS lists an RDA of 15 mcg (600 IU)/day for adults 19-70 years and 20 mcg (800 IU)/day after age 70. - Any convenient time; taking with a meal containing fat can aid absorption. - Ongoing nutritional intake.RDA values are population targets, not deficiency-treatment prescriptions.
  • Adult safety ceiling - Tolerable upper intake level: 100 mcg (4,000 IU)/day for adults from all sources. - Across the day as labeled. - Chronic intake.Higher therapeutic doses may be used by clinicians for deficiency but should not be self-prescribed long term.

Safety notes

  • Vitamin D toxicity and hypercalcemiaExcessive intake can cause hypercalcemia, hypercalciuria, kidney stones and severe renal or cardiac complications. Seek medical assessment if high-dose use or toxicity symptoms are present.
  • Kidney disease, granulomatous disease or calcium disordersConditions that alter calcium or vitamin D metabolism can change safety and dosing; supplementation should be clinician-guided.
  • High-dose self-treatmentDo not use repeated high-dose vitamin D protocols based only on nonspecific fatigue or performance concerns without appropriate assessment.

Interactions

  • Thiazide diuretics and other medicines affecting calcium balanceVitamin D can contribute to hypercalcemia in susceptible people; medication and disease context should be reviewed by a clinician or pharmacist.
  • Calcium supplementsCombined high intakes of calcium and vitamin D can increase hypercalcemia or kidney-stone risk in susceptible people; total intake matters.

References

  1. Sist M, et al.. Effects of vitamin D supplementation on maximal strength and power in athletes: a systematic review and meta-analysis Frontiers in Nutrition. 2023.Source
  2. NIH Office of Dietary Supplements. Vitamin D - Health Professional Fact Sheet National Institutes of Health. 2026.Source